Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849088) titled 'Efficacy Evaluation of Modified Zhixiao Tongmai Ning in Preventing Radiation-Induced Kidney Injury' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Peking University First Hospital
Condition:
Cancer Patients Receiving Radiotherapy for Kidney Malignancies
Intervention:
Drug: Modified Zhixiao Tongmai Ning
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: August 11, 2026
Target Sample Size: 194
Countries of Recruitment:
China
To know more, vi...